1XU7 image
Deposition Date 2004-10-25
Release Date 2004-11-02
Last Version Date 2024-02-14
Entry Detail
PDB ID:
1XU7
Keywords:
Title:
Crystal Structure of the Interface Open Conformation of Tetrameric 11b-HSD1
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.21
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Corticosteroid 11-beta-dehydrogenase, isozyme 1
Gene (Uniprot):HSD11B1
Mutations:C272S
Chain IDs:A, B, C, D
Chain Length:286
Number of Molecules:4
Biological Source:Homo sapiens
Primary Citation
Conformational Flexibility in Crystal Structures of Human 11beta-hydroxysteroid dehydrogenase type I provide insights into glucocorticoid interconversion and enzyme regulation.
J.Biol.Chem. 280 4639 4648 (2005)
PMID: 15513927 DOI: 10.1074/jbc.M411104200

Abstact

Human 11beta-hydroxysteroid dehydrogenase type I (11beta-HSD1) is an ER-localized membrane protein that catalyzes the interconversion of cortisone and cortisol. In adipose tissue, excessive cortisol production through 11beta-HSD1 activity has been implicated in the pathogenesis of type II diabetes and obesity. We report here biophysical, kinetic, mutagenesis, and structural data on two ternary complexes of 11beta-HSD1. The combined results reveal flexible active site interactions relevant to glucocorticoid recognition and demonstrate how four 11beta-HSD1 C termini converge to form an as yet uncharacterized tetramerization motif. A C-terminal Pro-Cys motif is localized at the center of the tetramer and forms reversible enzyme disulfides that alter enzyme activity. Conformational flexibility at the tetramerization interface is coupled to structural changes at the enzyme active site suggesting how the central Pro-Cys motif may regulate enzyme activity. Together, the crystallographic and biophysical data provide a structural framework for understanding 11beta-HSD1 activities and will ultimately facilitate the development of specific inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures